Results 1 to 10 of about 160,314 (274)

Macrophage activation syndrome

Indian Journal of Rheumatology, 2012
Abstract Macrophage activation syndrome (MAS) is a serious, potentially life-threatening complication of rheumatic disorders, which is seen most commonly in systemic juvenile idiopathic arthritis (sJIA). It is characterised clinically by unremitting high fever, pancytopaenia, hepatosplenomegaly, hepatic dysfunction, encephalopathy, coagulation ...
Bianca Lattanzi, Sergio Davi, Silvia Rosina, Nicoletta Solari, Stefano Lanni, Giulia Bracciolini, Alberto Martini, Angelo Ravelli   +7 more
doaj   +3 more sources

Macrophage Activation Syndrome in Viral Sepsis [PDF]

Viruses
Macrophage activation syndrome (MAS) is a life-threatening systemic hyperinflammatory syndrome triggered by various infections, particularly viral infections, autoimmune disorders, and malignancy. The condition is characterized by an increased production
Despoina Papageorgiou, Charalambos Gogos, Karolina Akinosoglou   +2 more
doaj   +4 more sources

Macrophage activation syndrome in a child with varicella: a case report [PDF]

Journal of Medical Case Reports
Background Macrophage activation syndrome is a severe, potentially fatal condition that belongs to the group of hemophagocytic lymphohistiocytosis.
H. Mateiko, O. Synoverska, M. Matvisiv, Z. Vovk, N. Horbal   +4 more
doaj   +2 more sources

Macrophage activation syndrome revealing Hodgkin´s lymphoma: a case report

The Pan African Medical Journal, 2021
Macrophage activation syndrome (MAS) is a rare immunologic syndrome, rapidly fatal in the absence of specific etiological treatment. It is defined by clinical, biological and cyto-histological criteria. Numerous etiologies have been described in MAS, the
Mustapha Mechtoune, Rajae Tissir, Ilias Tazi   +2 more
doaj   +2 more sources

Adult-onset Still’s disease with secondary macrophage activation syndrome: a case report

Italian Journal of Medicine, 2023
We describe a case of adult-onset Still’s disease (AOSD) with secondary macrophage activation syndrome. AOSD is a rare disease with unknown origin. Rarely it’s complicated by secondary macrophage activation syndrome, which is a life-threatening disorder.
Giuseppe Nicoletti, Antonio Bonelli, Rocco Clemente, Simona Ciuffreda, Gaetano Dentamaro, Agata Tiziana La Masa, Vito Lascaro, Pasquale Santarcangelo   +7 more
doaj   +3 more sources

Macrophage activation syndrome in systemic lupus erythematosus - a case report

Journal of Education, Health and Sport, 2023
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition that results from the immune system hyperactivation. The primary form of HLH appears mainly in children and is caused by a genetically determined failure of NK and T cells ...
Maciej Rogala, Karol Lorenc, Klaudia Jabłońska, Michał Kuc, Olga Bielawska, Tomasz Łoś, Kamila Giżewska, Marta Gulbicka   +7 more
doaj   +3 more sources

Clinical features and comorbidities of Epstein-Barr virus infection in childhood-onset systemic lupus erythematosus with a focus on macrophage activation syndrome: a cross-sectional study of 200 patients. [PDF]

Front Immunol
Wang H, Zhouyang M, Yang X, Zhang J, Yan H, Zhang Y, Li L, Zhao B.   +7 more
europepmc   +3 more sources

Heterogeneity of macrophage activation syndrome and treatment progression [PDF]

Frontiers in Immunology
Macrophage activation syndrome (MAS) is a rare complication of autoimmune inflammatory rheumatic diseases (AIIRD) characterized by a progressive and life-threatening condition with features including cytokine storm and hemophagocytosis.
Yuanji Dong, Ting Wang, Huaxiang Wu
doaj   +2 more sources

Macrophage activation syndrome complicating early course of adult-onset Still’s disease [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2021
Introduction. Adult-onset Still’s disease is a rare inflammatory disorder of unknown etiology. It can be complicated by macrophage activation syndrome, a potentially life-threatening condition. While macrophage activation syndrome and adult-onset Still’s
Božić Ksenija, Elez Marija, Glišić Branislava   +2 more
doaj   +1 more source

Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria. [PDF]

Arthritis Rheumatol
Erkens RGA, Rogani G, Huber L, Verwoerd A, Schonenberg-Meinema D, van den Berg JM, Armbrust W, Legger GE, Kamphuis S, Schatorjé EJH, Hoppenreijs EPAH, Swart JF, Jansen MHA, van Loosdregt J, Vastert SJ.   +14 more
europepmc   +3 more sources